Clinical Gastroenterology and Hepatology PDF

Clinical Gastroenterology and Hepatology (CGH) is a peer-reviewed journal with a clear mission and scope focusing on clinical gastroenterology and hepatology. Here are the key aspects that define CGH:

Mission and Scope:

• The mission of CGH is to provide readers with a comprehensive range of topics within clinical gastroenterology and hepatology. This includes covering diagnostic, endoscopic, interventional, and therapeutic advancements in areas such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion.
• The journal aims to publish articles that are immediately relevant to the practice of gastroenterology and hepatology. This includes original articles, scholarly reviews, key reviews, and articles on endoscopy/practice-based technology, health-care policy, and practice management.

Content Offerings:

• CGH features a wide range of content, including multimedia elements such as images, video abstracts, and podcasts. This approach enhances the accessibility and engagement of the journal’s content.
• The journal provides updates and commentary through social media platforms like Facebook and Twitter, further promoting interaction and information sharing.

Impact and Recognition:

• CGH is recognized for its impact in the field, and it is ranked 7th out of 93 journals in the gastroenterology and hepatology category according to the 2021 Journal Citation Reports© published by Clarivate Analytics. It boasts an impressive Impact Factor of 13.576.
• Authors submitting their work to CGH can expect timely decisions on their manuscripts, typically within less than three weeks.
• The journal maintains a rigorous review process, resulting in an acceptance rate of 12%.
• CGH has a substantial global reach, being circulated to 20,300 individuals and institutions worldwide.

Clinical Gastroenterology and Hepatology serves as a prominent resource for practitioners, researchers, and experts in the fields of gastroenterology and hepatology. The journal’s commitment to providing valuable and timely content is evident in its impressive impact and recognition in the medical community.

• Laurent Castera MD, PhD – UMR1149 (Center of Research on Inflammation), French Institute of Health and Medical Research, Université Paris Cité, Paris, France; and Service d’Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France
• Mazen Noureddin MD, MHSc – Houston Research Institute, Houston Methodist Hospital, Houston, Texas
• Lai Wei MD – Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China
• Charles Kahi MD, MSc – Indiana University School of Medicine, Indianapolis, Indiana